Patents Assigned to Abbott Laboratories
  • Patent number: 11536739
    Abstract: Example automated diagnostic analyzers and methods for using the same are disclosed herein. An example apparatus described herein includes a first carousel rotatably coupled to a base and having a first axis of rotation. The example apparatus includes a second carousel rotatably coupled to the base and vertically spaced over the first carousel such that at least a portion of the second carousel is disposed over the first carousel. In the example apparatus, the second carousel has a second axis of rotation and a plurality of vessels. The example apparatus also includes a pipetting mechanism offset from the second axis of rotation. The example pipetting mechanism is to access the first carousel and the second carousel.
    Type: Grant
    Filed: August 18, 2020
    Date of Patent: December 27, 2022
    Assignee: Abbott Laboratories
    Inventors: Brian L. Ochranek, David C. Arnquist, Takehiko Oonuma, Hirotoshi Tahara, Naoto Sato
  • Patent number: 11524018
    Abstract: Disclosed are nutritional compositions including human milk oligosaccharides in combination with long chain polyunsaturated fatty acids and/or carotenoids that can be administered to preterm infants, term infants, toddlers, and children for reducing inflammation and the incidence of inflammatory diseases.
    Type: Grant
    Filed: November 20, 2017
    Date of Patent: December 13, 2022
    Assignee: ABBOTT LABORATORIES
    Inventors: Rachael Buck, Geralyn O. Duska-McEwen, Joseph P. Schaller
  • Patent number: 11514737
    Abstract: Digital pass verification systems and methods are disclosed herein. An apparatus disclosed herein includes memory including instructions that, when executed, cause processor circuitry to: access a result of a diagnostic test associated with a test kit identification; associate the result of the diagnostic test with a user identification; and transmit the result of the diagnostic test and the test kit identification to a first device to cause the first device to generate a machine-readable pass on a display of the first device.
    Type: Grant
    Filed: March 22, 2021
    Date of Patent: November 29, 2022
    Assignee: Abbott Laboratories
    Inventors: Nitesh Luthra, Lev F. Frayman, Terry Finch, John Schullian, Douglas Wager, Nicholas Alexander Robertson Wood
  • Patent number: 11514738
    Abstract: Digital pass verification systems and methods are disclosed herein. One or more servers are to distribute instructions on a network. The instructions, when executed, cause a first device carried by a person to at least: access a result of a diagnostic test performed on the person, the result provided by a second device; generate a machine-readable code in response to the result being negative; and display the machine-readable code on a display of the first device to enable the person to gain access to a location.
    Type: Grant
    Filed: April 26, 2021
    Date of Patent: November 29, 2022
    Assignee: Abbott Laboratories
    Inventors: Nitesh Luthra, Lev F. Frayman, Terry Finch, John Schullian, Douglas Wager, Nicholas Alexander Robertson Wood
  • Patent number: 11492658
    Abstract: Disclosed are methods for detecting a target nucleic acid in a sample. The methods include contacting the sample, in the presence of a polymerase and an endonuclease, with a first oligonucleotide comprising, in the 5? to 3? direction, a first signal DNA generation sequence, an endonuclease recognition site, and a sequence complementary to the 3? end of a target nucleic acid; a second oligonucleotide comprising, in the 5? to 3? direction, a second signal DNA generation sequence, an endonuclease recognition site, and a sequence that is homologous to the first signal DNA generation sequence of the first oligonucleotide; a third oligonucleotide comprising, in the 5? to 3? direction, a third signal DNA generation sequence, an endonuclease recognition site, and a sequence that is homologous to the second signal DNA generation sequence of the second oligonucleotide.
    Type: Grant
    Filed: March 12, 2020
    Date of Patent: November 8, 2022
    Assignee: ABBOTT LABORATORIES
    Inventors: Makoto Komori, Toru Yoshimura
  • Publication number: 20220346429
    Abstract: Disclosed embodiments provide nutritional compositions and methods of enhancing maturation of an infant's brain. The methods include the step of administering to the infant a nutritional composition comprising a protein with a degree of hydrolysis of 10% to 75% in combination with at least one of a monoglyceride, a free fatty acid, a salt of a free fatty acid, a phospholipid, and cholesterol.
    Type: Application
    Filed: June 29, 2022
    Publication date: November 3, 2022
    Applicant: ABBOTT LABORATORIES
    Inventors: TAPAS DAS, MUSTAFA VURMA, CHRON-SI LAI, PAUL JOHNS
  • Publication number: 20220330596
    Abstract: Methods of preparing a nutritional product which contain a lipophilic nutrient are disclosed. The nutritional product is made using a fortifying powder containing the lipophilic nutrient, a monoglyceride and diglyceride (“MDG”) oil, a phospholipid, and a carrier. The fortifying powder enhances the digestive absorption of the lipophilic nutrient when the nutritional product is consumed. The fortifying powder simplifies the process of manufacturing the nutritional product, as the fortifying powder can be added at a suitable stage of the process with other powdered ingredients. The fortifying powder may be manufactured in bulk and stored for later use, thereby improving manufacturing efficiencies. The fortifying powder and methods of preparing the fortifying powder are also presented.
    Type: Application
    Filed: June 27, 2022
    Publication date: October 20, 2022
    Applicant: ABBOTT LABORATORIES
    Inventors: GARY GORDON, MUSTAFA VURMA
  • Patent number: 11464793
    Abstract: Disclosed are nutritional compositions including human milk oligosaccharides in combination with long chain polyunsaturated fatty acids and/or carotenoids that can be administered to preterm infants, term infants, toddlers, and children for reducing inflammation and the incidence of inflammatory diseases.
    Type: Grant
    Filed: November 16, 2020
    Date of Patent: October 11, 2022
    Assignee: ABBOTT LABORATORIES
    Inventors: Rachael Buck, Geralyn O. Duska-McEwen, Joseph P. Schaller
  • Patent number: 11452787
    Abstract: Methods and apparatus to reduce biological carryover using induction heating are disclosed herein. An example method includes washing an aspiration and dispense device. The example method includes generating an alternating electromagnetic field and introducing the aspiration and dispense device into the alternating electromagnetic field. The example method includes inductively heating the aspiration and dispense device with the alternating electromagnetic field. In the example method, the washing is to occur in concert with the heating.
    Type: Grant
    Filed: May 21, 2018
    Date of Patent: September 27, 2022
    Assignee: ABBOTT LABORATORIES
    Inventors: Brad Weston, Jeffrey Mitchell
  • Patent number: 11446316
    Abstract: Disclosed are nutritional compositions including galactooligosaccharides that can be administered to individuals including preterm infants, infants, toddlers, children, and adults for preventing injury and/or improving the healing of the gastrointestinal tract. Additional suitable methods of using the nutritional compositions including the galactooligosaccharides are also disclosed.
    Type: Grant
    Filed: July 19, 2012
    Date of Patent: September 20, 2022
    Assignee: ABBOTT LABORATORIES
    Inventors: Steven R. Davis, Jomay Chow
  • Patent number: 11435372
    Abstract: Diagnostic analyzers with pretreatment carousels and related methods are disclosed. An example apparatus includes a first carousel that includes a first annular array of slots to receive a first vessel. The example first carousel also includes a first track of rotation about the first carousel having a first diameter and a second track of rotation about the first carousel having a second diameter smaller than the first diameter. The example apparatus includes a first diverter to move the first vessel from the first track to the second track. In addition, the example apparatus includes a second carousel coaxial with the first carousel. The example second carousel includes a second annular array of slots to receive a second vessel.
    Type: Grant
    Filed: April 21, 2017
    Date of Patent: September 6, 2022
    Assignee: Abbott Laboratories
    Inventors: Brian L. Ochranek, David C. Arnquist
  • Patent number: 11428694
    Abstract: The present disclosure provides detection methods employing HCV core lipid binding domain and DNA binding domain monoclonal antibodies. In certain embodiments, the lipid binding domain monoclonal antibody recognizes an epitope in amino acids 141 to 161 of HCV core protein.
    Type: Grant
    Filed: April 15, 2021
    Date of Patent: August 30, 2022
    Assignee: ABBOTT LABORATORIES
    Inventors: Robert Ziemann, April Ahlberg, David Hawksworth, Bryan Tieman, A. Scott Muerhoff, Christopher Marohnic, Kathy Otis
  • Patent number: 11421023
    Abstract: Disclosed herein are antibodies and methods of using said antibodies to detect Golgi protein 73 (GP73) and fucosylated GP73 in a sample.
    Type: Grant
    Filed: April 17, 2019
    Date of Patent: August 23, 2022
    Assignee: ABBOTT LABORATORIES
    Inventors: Bailin Tu, Robert N. Ziemann, Bryan C. Tieman, Philip M. Hemken, Carol S. Ramsay, Carolyn J. Strobel, David J. Hawksworth, Larry G. Birkenmeyer, Cheng Zhao, Susan E. Brophy, Barry L. Dowell, Anthony S. Muerhoff
  • Publication number: 20220249527
    Abstract: Disclosed are methods of reducing the incidence of oxidative stress in infants, toddlers, and children using nutritional compositions including human milk oligosaccharides. The nutritional compositions including the human milk oligosaccharides are effective at reducing inflammation and the incidence of inflammatory diseases.
    Type: Application
    Filed: April 25, 2022
    Publication date: August 11, 2022
    Applicant: ABBOTT LABORATORIES
    Inventors: Steven R. DAVIS, Rachael BUCK, Geralyn O. DUSKA-MCEWEN
  • Patent number: 11399559
    Abstract: Methods of preparing a nutritional product which contain a lipophilic nutrient are disclosed. The nutritional product is made using a fortifying powder containing the lipophilic nutrient, a monoglyceride and diglyceride (“MDG”) oil, a phospholipid, and a carrier. The fortifying powder enhances the digestive absorption of the lipophilic nutrient when the nutritional product is consumed. The fortifying powder simplifies the process of manufacturing the nutritional product, as the fortifying powder can be added at a suitable stage of the process with other powdered ingredients. The fortifying powder may be manufactured in bulk and stored for later use, thereby improving manufacturing efficiencies. The fortifying powder and methods of preparing the fortifying powder are also presented.
    Type: Grant
    Filed: July 28, 2016
    Date of Patent: August 2, 2022
    Assignee: ABBOTT LABORATORIES
    Inventors: Gary Gordon, Mustafa Vurma
  • Patent number: D958819
    Type: Grant
    Filed: July 28, 2020
    Date of Patent: July 26, 2022
    Assignee: Abbott Laboratories
    Inventors: Rahul Avasthy, Christopher Gorz, Olya Androsik
  • Patent number: D959468
    Type: Grant
    Filed: March 12, 2021
    Date of Patent: August 2, 2022
    Assignee: Abbott Laboratories
    Inventors: Rahul Avasthy, Christopher Gorz, Olga Androsik
  • Patent number: D959469
    Type: Grant
    Filed: March 12, 2021
    Date of Patent: August 2, 2022
    Assignee: Abbott Laboratories
    Inventors: Rahul Avasthy, Christopher Gorz, Olga Androsik
  • Patent number: D961607
    Type: Grant
    Filed: March 12, 2021
    Date of Patent: August 23, 2022
    Assignee: Abbott Laboratories
    Inventors: Rahul Avasthy, Christopher Gorz, Olga Androsik
  • Patent number: D962471
    Type: Grant
    Filed: December 17, 2020
    Date of Patent: August 30, 2022
    Assignee: Abbott Laboratories
    Inventors: Robert Paul Luoma, II, Brian L. Ochranek, Cheryl L. Davidson, Bradley C. Weston